Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

95% upper bound limit as per FDA for fully replicate crossover BE study [RSABE / ABEL]

posted by dshah – India, 2021-01-05 09:06 (1379 d 02:22 ago) – Posting: # 22174
Views: 2,729

Hi Yogeshla!

❝ Suppose 95% UB result is 0.001, is it acceptable to FDA?

The 95% UB would not be acceptable for 0.001.

Regards,
dshah

Complete thread:

95% upper bound limit as per FDA for fully replicate crossover BE study yogeshla 2021-01-05 07:01 [RSABE / ABEL]
- 95% upper bound limit as per FDA for fully replicate crossover BE studydshah 2021-01-05 08:06
  - 0.001 > 0 Helmut 2021-01-05 11:01
    - 0.001 > 0 yogeshla 2021-01-05 12:33

Admin contact
23,258 posts in 4,886 threads, 1,671 registered users;
80 visitors (0 registered, 80 guests [including 5 identified bots]).
Forum time: 12:28 CEST (Europe/Vienna)

Tortured data will confess to anything. Fredric Menger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz